Clinical Trial

Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2025 (before its estimated February 7, 2025 completion). Its status may not reflect the trial's current state.
Summary
Analyzing the effectiveness of nebulized dexmedetomidine 2 mcg/kg in reducing the incidence of post-anesthesia delirium in preschool children undergoing elective surgery with sevoflurane inhalation general anesthesia. Researchers will compare nebulized Dexmedetomidine to a placebo (a look-alike substance that contains no drug) to see if the drug can reduce post anesthesia delirium incidence.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-04.
Trial Details
NCT Number NCT06761092
Lead Sponsor Udayana University
Conditions Emergence Delirium, Delirium - Postoperative
Enrollment 72 participants
Start Date 2024-12-13
Primary Completion 2025-02-07 (estimated)
Study Completion 2025-02-13 (estimated)
Updated on ClinicalTrials.gov 2025-01-22